TABLE 1.
Cancer stem cell (CSC) biomarkers for gastric and colorectal cancer.
Gastric Cancer |
Colorectal Cancer |
|
CSCs biomarkers | References | References |
CD44 | Takaishi et al., 2009; Zhang X. et al., 2016 | Du et al., 2008; Huang et al., 2015 |
CD44 combined with CD24 | Zhang et al., 2011 | — |
CD44 combined with CD54 | Chen et al., 2012 | — |
CD44 combined with EpCAM | Han et al., 2011 | Dalerba et al., 2007b |
CD44 combined with CD133 | — | Huang et al., 2015 |
CD49f | Fukamachi et al., 2013 | Haraguchi et al., 2013 |
CD71 | Ohkuma et al., 2012 | — |
CD90 | Jiang J. et al., 2012 | — |
CD133 | Fukamachi et al., 2011; Zhang X. et al., 2016 | O’Brien et al., 2007; Ricci-Vitiani et al., 2007; Huang et al., 2015 |
CD133 combined with CD166 | — | Dalerba et al., 2007b |
CD184 (CXCR4) | Fujita et al., 2015 | — |
CD200 | — | Zhang S.S. et al., 2016 |
Lgr5 | Gong et al., 2016 | — |
Lgr5 combined with EpCAM | — | Kemper et al., 2012 |
Lgr5 combined with EpCAM and CD44 | — | Leng et al., 2018 |
ALDH | Zhi et al., 2011 | Huang et al., 2009 |
SOX2 | Pádua et al., 2020 | Takeda et al., 2018 |
The table contains some of the most reported CSCs markers used for both tumor types.